The ‘Cannabis Basket’ Approach for Long-Term Gains: 3 Stocks to Consider

With the volatility in the stock market and especially the cannabis sector these days, one way to invest for the long-term is to buy a basket of stocks. The sector

Read more »

4 Cannabis Stocks You’ll Regret Not Buying During This Correction

Batten down the hatches, because volatility has returned in a big way for the stock market. Over a 12-session stretch, ending this past Tuesday, March 10, the 123-year-old Dow Jones Industrial

Read more »

U.S. or Canadian Pot Stocks: The Better Buy Is…?

Over the next decade, cannabis is expected to be one of the fastest-growing industries. After more than tripling worldwide sales to $10.9 billion between 2014 and 2018, Wall Street is

Read more »

Canopy Growth Makes a $59 Million Loan

During these volatile times in the market, capital can be scarce. Companies with weak balance sheets need to do everything and anything to preserve their capital and cut costs. Canopy

Read more »

Why We Like OrganiGram (OGI) at These Levels

With the overall bearish sentiment dragging the cannabis sector down, OrganiGram (OGI) might be a “diamond in the rough” that’s just caught in a sector-wide selloff. Although the stock is

Read more »

Why Canopy Growth Stock Is Rebounding Today

Shares of Canopy Growth (NYSE:CGC) were up 3.6% as of 11:31 a.m. EDT on Tuesday after rising as much as 10.8% earlier in the day. The small rebound for the Canadian cannabis

Read more »

The Largest Pot Stock in the World Is Cutting Production Big Time

Roughly a year and a half ago, Canadian marijuana stocks were expected to take the global lead in making cannabis a mainstream product. But despite having this pole position among

Read more »

Why is Canopy Growth (CGC) Trading Down More Than 10% in the Past 2 Days?

Cannabis companies continue to be challenged by the bottleneck that exists in Canada.  The lack of support and inaction by the Canadian federal and provincial governments for a once booming industry

Read more »

Why Shares of Cronos (CRON) aren’t Falling With the Rest of the Cannabis Sector

On Wednesday, MKM Partners analyst Bill Kirk upgraded Cronos Group (CRON) to a buy from a neutral rating. This comes after CRON announced that they would be delaying their fourth-quarter

Read more »

2 Reasons Marijuana Stocks Are Suffering From the Coronavirus Outbreak

Most marijuana stocks have taken a beating in recent weeks. The Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF), which includes over 50 top pot stocks in its holdings, is down more

Read more »